ArticleCell death & disease2025

Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinoma.

Bo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.